Kashi Clinical Laboratories

Portland, United States Founded: 2006 • Age: 20 yrs Acquired By Prairie Capital
Provides laboratory testing for clinical pathology, genomics, and toxicology services.
Annual revenue - Latest available
Total funding - Funding intelligence
Employees - Tracked headcount
Investors 1 Known backers
Products 4 Services tracked
Competitors 11 Brand Intelligence

About Kashi Clinical Laboratories

Kashi Clinical Laboratories is a company based in Portland (United States) founded in 2006 was acquired by Prairie Capital in June 2024. It operates as a B2B. Kashi Clinical Laboratories offers products and services including Genetic Testing, Toxicology Testing, Virology Testing, and Clinical Pathology. Kashi Clinical Laboratories operates in a competitive market with competitors including Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.

  • Headquarter Portland, United States
  • Sectors
    Healthcare
  • Phone
    Locked
  • Website
    Locked
  • Social
    Locked
Operational Areas
Healthcare → Medical Devices & Diagnostics Unlock Sub-Sector Unlock Segment
Healthcare → Biotechnology, Genomics & Life Sciences Research Unlock Sub-Sector Unlock Segment
Key Metrics
  • Annual Revenue
    Not available
  • Net Profit
    Not available
  • EBITDA
    Not available
  • Latest Funding Round
    Not available
  • Investors
  • Employee Count
    Not available
  • Acquired by
    Prairie Capital

    (Jun 01, 2024)

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of Kashi Clinical Laboratories

Kashi Clinical Laboratories offers a comprehensive portfolio of products and services, including Genetic Testing, Toxicology Testing, Virology Testing, and Clinical Pathology.

Product name locked
Category locked
Primary

Identifies genetic variations for disease diagnosis and risk assessment.

Product name locked
Category locked
Locked

Analyzes drug sensitivity and metabolism for medical and environmental use.

Product name locked
Category locked
Locked

Conducts PCR and serological tests to detect viral infections accurately.

Product name locked
Category locked
Locked

Performs chemistry and hematology tests for overall health monitoring.

People of Kashi Clinical Laboratories

Headcount 50-200
Employee Profiles 6
Employee Profiles
People
Masataka Hayashi
Vice President Of Finance
People
Zahra Kashi
CEO And Lab Director
People
Dawn Thomas Smith
Director Of Marketing
People
Sean Toddy
Vice President, HLA Client Development, Bone Marrow Transplant Services

Unlock access to complete

Funding Insights of Kashi Clinical Laboratories

Premium access

Detailed funding history for Kashi Clinical Laboratories

Round names, dates, amounts, investors, and valuation history require an active premium plan.

  • Round names and dates
  • Funding amounts
  • Participating investors
  • Valuation history

Verified entity values are shown only after access is granted.

Investors in Kashi Clinical Laboratories

Kashi Clinical Laboratories has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Prairie Capital.

All
Venture Fund
Investor Description Founded Year Domain Location
Prairie Capital is focused on scaling lower middle market companies.
Locked Locked Locked
Premium access

Investor details for Kashi Clinical Laboratories

Investor domains, locations, round participation, and complete history require an active premium plan.

  • Investor domains
  • Investor locations
  • Funding rounds
  • Participation history

Verified entity values are shown only after access is granted.

Investments & Acquisitions by Kashi Clinical Laboratories

Investments
Premium access

Investment portfolio details for Kashi Clinical Laboratories

Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.

  • Portfolio identities
  • Transaction dates
  • Round details
  • Investment values

Verified entity values are shown only after access is granted.

Financial Statements - Kashi Clinical Laboratories

Premium access

Detailed financials for Kashi Clinical Laboratories

Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.

  • Historical revenue
  • Profit trends
  • Statement rows
  • Financial ratios

Verified entity values are shown only after access is granted.

Kashi Clinical Laboratories Comparisons

Kashi Clinical Laboratories Primary company
Description
Provides laboratory testing for clinical pathology, genomics...
Location
Portland, United States
Founded Year
2006
Annual Revenue
Not available
Net Profit
Not available
EBITDA
Not available
Employees
Not available
Premium access

Peer comparison for Kashi Clinical Laboratories

Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.

  • Named peers
  • Headcount comparison
  • Funding comparison
  • Operating benchmarks

Verified entity values are shown only after access is granted.

+
Add Comparison
Available on Premium

Competitors of Kashi Clinical Laboratories

Kashi Clinical Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Omniome, Tessera Therapeutics, HitGen, Phase Genomics and Hexagon Bio, among others.

Company Name Domain Founded year HQ Location Description
Locked Locked Locked
Genome sequencing platform is provided for clinical diagnostics.
Locked Locked Locked
New genome engineering technology is provided for treating multiple diseases.
Locked Locked Locked
DNA-encoded libraries are developed for drug discovery applications.
Locked Locked Locked
Laboratory and computational services for DNA proximity analysis are provided.
Locked Locked Locked
Bioinformatics tools are provided for analyzing microbial genomic sequencing data.
Locked Locked Locked
Genomic services and solutions with NGS expertise are provided.
Premium access

Detailed competitors of Kashi Clinical Laboratories

Competitor domains, locations, full profiles, and operating metrics require an active premium plan.

  • Domains and locations
  • Full company profiles
  • Operating metrics
  • Competitive positioning

Verified entity values are shown only after access is granted.

Latest news on Kashi Clinical Laboratories

Premium access

Complete news archive for Kashi Clinical Laboratories

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Kashi Clinical Laboratories

Kashi Clinical Laboratories was founded in 2006.

Kashi Clinical Laboratories is headquartered in Portland, United States. It is registered at Portland, Oregon, United States.

Kashi Clinical Laboratories specializes in diagnostic testing, including clinical pathology, genomics, genetic testing, and toxicology. They deliver services to healthcare providers and patients through rapid turnaround times and EHR integration. Based in Portland, Oregon, they focus on molecular and environmental testing to support disease diagnosis and health monitoring. Their consultative approach ensures high-quality results for clinical trials and virology.

Kashi Clinical Laboratories's top competitors include Tessera Therapeutics, Novogene Corporation and Phase Genomics.

Kashi Clinical Laboratories offers Genetic Testing, Toxicology Testing, Virology Testing, and Clinical Pathology.

Kashi Clinical Laboratories has 1 investor. Key investors include Prairie Capital.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available